1. Home
  2. SYPR vs CELU Comparison

SYPR vs CELU Comparison

Compare SYPR & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sypris Solutions Inc.

SYPR

Sypris Solutions Inc.

HOLD

Current Price

$2.42

Market Cap

47.7M

Sector

Industrials

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.07

Market Cap

50.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYPR
CELU
Founded
1997
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
50.7M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
SYPR
CELU
Price
$2.42
$1.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
70.2K
88.8K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$123,055,000.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$1.00
52 Week High
$3.72
$4.35

Technical Indicators

Market Signals
Indicator
SYPR
CELU
Relative Strength Index (RSI) 59.68 27.99
Support Level $2.11 $1.25
Resistance Level $2.72 $1.37
Average True Range (ATR) 0.21 0.15
MACD 0.00 -0.03
Stochastic Oscillator 56.45 9.88

Price Performance

Historical Comparison
SYPR
CELU

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: